| GTO ID | GTC0970 |
| Trial ID | ChiCTR2200056457 |
| Disease | Multiple Myeloma |
| Therapy | CAR-T cell |
| Treatment | C-4-29 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I clinical Trial of chimeric antigen receptor T lymphocyte (C-4-29) preparation in patients with recurrent/refractory multiple myeloma |
| Year | 2022 |
| Country | China |
| Company sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology/West China Hospital of Sichuan University |
| Cohort 1 | |||||||||
|
|||||||||